Pfizer is saying today that it does not intend to extend a firm offer for AstraZeneca, bringing an end to its attempt to acquire the UK drug maker. AZ shareholders were split on the latest offer, and a stumble by AZ would probably bring many of them back to the negotiating table. Per UK securities law, a six month month cooling off period now follows. I’m guessing Pfizer will be waiting, and watching.
Join 37 other subscribers